Drugs / BMS-986183
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02828124 | Aug 2016 → Jan 2018 | hepatocellular carcinoma | Bristol-Myers Squibb | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-986183 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02828124 ↗ |